This Government Contract opportunity from Department Of Defense was posted on September 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Supply of Ringer's Injection Lactated, USP

Closed

Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

Federal

Latanoprost Ophthalmic Solution ManufacturingThis subcontract involves the manufacturing of Latanoprost Ophthalmic Solution to support prime contractors on pharmaceutical procurement projects for the Department of Veterans Affairs. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and sterile filling into ocular medication containers. All operations must be conducted within cleanrooms using pharmaceutical-grade API and in strict adherence to current Good Manufacturing Practices. To ensure safety and standardization, the manufacturer must follow the American Academy of Ophthalmology’s uniform color-coding system for all labels and caps. The final deliverable consists of finished, labeled, and packaged solutions assigned a unique NDC number. This project is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026. Strict labeling and packaging requirements apply to this procurement. Offerors must provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the only one on the product, and affixing labels over existing ones is prohibited; however, the product must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements, and all electronic communications and submissions will be handled via SAM.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Bismuth Subsalicylate SuspensionThis subcontract involves the supply of finished pharmaceutical products to prime contractors supporting DLA Troop Support medical supply contracts. The specific requirement is for the delivery of 2,000 bottles of Bismuth Subsalicylate Suspension, with a strength of 262 MG/15 ML in 240 ML bottles, identified by NSN 6505015056483. All deliverables must strictly adhere to RP001 DLA Packaging Requirements for Procurement. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract is categorized under NAICS code 325412. The designated place of performance is Fort Drum, New York. The solicitation was posted on October 1, 2026, with a response deadline of October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ibuprofen Oral Suspension, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Occlusive Adhesive Dressing SupplierThis subcontract opportunity is for a supplier to provide occlusive adhesive dressings for prime contractors supporting Medical Supply Chain MD SURG FSF projects under the Department of Defense. The selected provider must manufacture or source dressings that strictly adhere to established technical specifications. All units must be packed in sealed containers and commercial exterior shipping containers for transport via common carrier, requiring the supplier to maintain a CAGE code and follow standard commercial packaging guidelines. The project is categorized under NAICS code 325412 and will be performed in Springfield, Missouri. Interested parties must respond by October 7, 2026, to be considered for the delivery of these physical medical supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Albendazole Tablets, USPThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Albendazole Tablets, USP, for prime contractors supporting DLA Troop Support medical supply contracts. The requirement is for 168 bottles of tablets under NSN 6505-01-649-3422, which must meet all USP specifications and be delivered FOB Destination to Fort Bragg. The supplier must maintain FDA registration and ensure the product is packaged in bottles with a non-extendable 24-month shelf life, designated as Type I, Code M. This procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Poison Ivy Skin Wash

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Multiple Electrolytes Injection, Type 1

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Loperamide Hydrochloride CapsulesThis subcontract involves the supply of 2,000 bottles of Loperamide Hydrochloride Capsules, each containing 500 capsules of 2mg strength, to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The medication must be pharmaceutical-grade and strictly compliant with NSN 6505012813558, requiring the provider to maintain valid FDA approval and necessary pharmaceutical licensure. Performance of this contract takes place at Fort Bragg and requires strict adherence to DLA packaging requirements RP001 and hazardous materials standards IP025. The procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluconazole Tablets 150 MG

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ceftriaxone Sodium in Dextrose InjectionThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Ceftriaxone Sodium in Dextrose Injection to prime contractors for DLA Troop Support medical supply contracts. The requirement is for five packages, each containing 24 plastic bags of 1 gram Ceftriaxone frozen and premixed in an iso-osmotic solution with 1.9 gram dextrose. To ensure product integrity, the contractor must utilize cold-chain storage and transport equipment to maintain a temperature of -20 degrees Celsius per USP standards, with packaging adhering to MIL-STD-2073-1E. The performance location for this contract is FPO 09566-4008, and the response deadline is October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lactated Ringer's Injection, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

This subcontract involves the supply of 7,000 total units of Ringer's Injection Lactated, USP, provided in 1000ML 12-packs for prime contractors supporting Department of Defense supply contracts. The pharmaceutical-grade IV fluids must adhere to United States Pharmacopeia standards and be marked according to Medical Marking Standard No. 1. All participating providers are required to hold valid FDA-approved pharmaceutical manufacturing or distribution licenses. The contract is managed by the Medical Supply Chain Pharm FSA and is designated for performance at Fort Stewart, Georgia. Under NAICS code 325412, the solicitation was posted on September 2, 2026, with a response deadline of September 8, 2026.

General Info

Supply 7,000 units of Ringer's Injection Lactated for DoD at Fort Stewart, Georgia.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FORT STEWART, GA, 31314-5185, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4882.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

RINGER'S INJECTION, LAC

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedSep 2

subcontract

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Supplies Ringer's Injection Lactated, USP, 1000ML, 12-packs for prime contractors delivering DLA supply contracts. Provides pharmaceutical-grade IV fluids meeting United States Pharmacopeia (USP) standards and marks materials in accordance with Medical Marking Standard No. 1 (MMS No. 1). Requires FDA-approved pharmaceutical manufacturing or distribution licenses. Delivers 7,000 total units of commercial packaged IV fluids.